Clinical Trials in Phoenix

Showing 1321-1340 of 14,291 trials

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

NCT04903314

The primary objective of this study is to assess the pharmacokinetics of cenobamate (YKP3089) in pediatric subjects with partial-onset (focal) seizures following single and multiple-dosing.

Partial Epilepsy

SK Life Science, Inc.26 participantsStarted May 2021

Phoenix, Arizona, United States • Bethesda, Maryland, United States • Columbia, Missouri, United States +10 more locations

Active Not RecruitingNA< 1 mile

Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer

NCT05683691

The purpose of this study is to evaluate the safety and efficacy of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate cancer.

Prostate Cancer

Francis Medical Inc.400 participantsStarted May 2023

Phoenix, Arizona, United States • Laguna Hills, California, United States • Los Angeles, California, United States +23 more locations

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer

Find Trials by Condition in Phoenix

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain

Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls.

Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations

Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study

A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

REALITY LHON Registry

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

Open-Label Extension of EryDex Study IEDAT-04-2022

A Study of LY4175408 in Participants With Advanced Cancer

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma